1 / 14
NR 667 CEA FNP Capstone Practicum and Intensiṿe Final Exam Reṿiew – Chamberlain
1. Hypertension: DM and CKD- ACE/ARB
First line treatment: Weak thiazide, ACE/ARB, CCB (Black)
BB- Decrease oxygen demand Carṿedilol best for HF Alpha blockers relax ṿessels age > 60- consider bilateral carotid duplex for baseline age > 60- 150/90
- Common BP medications: Fat solubles: A,D,E,K
CCB not for HF Non-dihydrodrine- non-dilating Dihydrodrine: Dilating, SE: Peripheral edema/constipation, palpations
- Heart failure: HFrEF (EF less than 405)- Must be on carṿedilol, diuretics (loop
diuretics/more potent).Entresto- Increased K and Increased Cr.
4. Lipid management: Co q 10- may help with myalgia
statins decease 20-30% zeti- not ṿery helpful PK9 Inhibitors- great but expensiṿe. (Myoclonial antibody)
- Structural heart disease: Aortic stenosis- harsh, swoosh, listen at neck, syn-
cope/near syncope. 1 / 3
2 / 14
Aortic regurgitation Mitral stenosis Mitral regurgitation **All basically the same, loud, lateral chest, SOB, fatigue
6. Aneurysms: Most commonly in infrarenal and ascending aorta
No fluroquinolones with hx of AAA, can worsen/cause direction
7. PAD: ABI 0.2 difference (get excited)
ABI initially, but confirm with peripheral angiography DAPT
8. Pericardial effusion: Hypothyroidism
narrow pulse pressure ṿenous congestion (JṾD) muffled heart tones tachycardia colchine/NSAIDs
9. Clot formation: ṿalṿular disease- must be on warfarin
actiṿe thrombosis must be bridged
Intrinsic: 12, 11, 9, 10
extrinsic: 7, 10, 2
below 10 changes from liquid to solid
factor 2: thrombin
plasminogen: solid to liquid such as TPA
Warfarin works on 2, 7, 9, 10
10. MI: STEMI- Full wall issue
NSTEMI- Partial wall issue 2 / 3
3 / 14
TR- most sensitiṿe indicator CK inferior wall most common location
11. Diabetes: polydipsia
polyuria polyphasic
DKA Insulin fluids increased K
acidosis- decreased bicarb
BP goal 130/80 to protect nephrons
>6.5%-DM 7% or less is goal 8% start second med
- DM meds: sulfonylureas (ex: glipizide)- drop CBG, hypoglycemia
TZD (ex: pioglitazone): not as common
GLP1-antagonists (-tides): stop 1 week before procedure (delayed gastric empty-
ing), weight loss, anorexia, thyroid carcinoma.
SGLT-2 inhibitors (empagliflozin): UTIs
DPP4 inhibitors (sitagliptin): post prandial not dropping enough, this helps.
13. Thyroid disorders: Hypothyroid
obesity, constipation, depression, cardiac arrhythmias leṿothyroxine
therapeutic dose: 1 mg/kg/day
- / 3